Abstract:The purpose of the present study was to prepare a clonidine hydrochloride (CH) sustained-release suspension.The processes involved in the drug formulation included drug loading, impregnating, and suspension preparation. Clonidine hydrochloride drug–resin complexes (CH-DRC) were prepared using the bath method and the CH-DRC impregnated before the microencapsulation process. Based on the bottom spray fluidized bed coating method, the CH microencapsulated drug–resin complexes (CH-MC) were also prepared using Surelease® (the suspension of ethyl cellulose aqueous dispersion) as the coating material. The effects of coating (process/formulation) on the in vitro release of coating microcapsule were evaluated via single factor investigation and orthogonal design optimization. The CH-MC with optimized formulation was further dispersed in a suitable medium to obtain a sustained-release suspension. Rats were given commercial CH ordinary tablets and the CH sustained-release suspension via intragastric administration. The plasma concentration–time curve and related pharmacokinetic parameters were investigated using the non-compartment model.The Tmax of the CH sustained-release suspension was delayed from 2 h to 5 h compared with the CH ordinary tablets. Similarly, the Cmax was reduced from 32.138 µg·mL−1 to 18.150 µg·mL−1 with the concentration–time curve being more gentle compared with the commercially CH ordinary tablets. After oral administration, the relative bioavailability of CH sustained-release suspension (AUC0–24 of 137.703 µg·h·mL−1) to its CH ordinary tablets (AUC0–24 of 123.337 µg·h·mL−1) was 111.65%.The findings showed that the CH sustained-release suspension for oral administration was successfully formulated.

Optimization of Compound Hydrochlorothiazide/clonidine Hydrochloride SUS-tained-release Preparation by Central Composite Design/response Surface Methodology

Optimization of Ambroxol Hydrochloride Sustained-Release Tablets Formulation by Central Composite Design-Response Surface Methodology

Optimization of Levofloxacin Hydrochloride Sustained-release Tablets by Central Composite Design

Optimization of formulation for colon-targeted tablets with sinomenine hydrochloride by central composite design-response surface method

Optimization of Cudrania Extractum Tablets Formulation by Central Composite Design-Response Surface Methodology

Optimization of Sustained Release Matrix Tablet of Metoprolol Succinate Using Central Composite Design.

Optimized Formulation of Rizatriptan Benzoate Tablet by a Central Composite Design/Response Surface Methodology

Optimization of the Formulation of Bezafibrate Osmotic Pump Tablets by Central Composite Design-response Surface Methodology

Optimization of the Biphasic Release of Indomethacin from HPMC/pectin/calcium Chloride Matrix Tablet by Response Surface Methodology

Optimized Preparation of Silymarin Dropping Pill by a Central Composite Design-Response Surface Method

Optimization of Immediate-release Pellets Formulation of Hydrochlorothiazide by Box Behnken Design

Application of the custom design methodology in the buflomedil hydrochloride sustained release tablets formulation

Optimization of Mirabegron Sustained-release Tablets by Central Composite Design-response Surface Meth-od

Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology

Formulation Optimization of Vitamin C Vaginal Bioadhesive Sustained-release Tablets by Central Composite Design

Optimization of Coating Formulation of Memantine Hydrochloride Sus-tained -release Pellets by Central Composite Design -Response Surface Methodology

Optimization of pramipexole hydrochloride sustained-release tablets using Box-Behnken design and mechanism of in vitro drug release

Evaluation of Carbopol 71G and HPMC As Matrix Materials in a Sustained Release Formulation

Optimization of Extended Zero-order Release Gliclazide Tablets Using D-optimal Mixture Design

Optimization of isosorbide mononitrate microporosity osmotic pump tablets formulation using response surface methodology

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation